Tomosada Yoshikawa
Directeur/Bestuurslid bij KLAB INC.
Actieve functies van Tomosada Yoshikawa
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KLAB INC. | Directeur/Bestuurslid | 25-03-2018 | - |
| Independent Dir/Board Member | 25-03-2018 | - | |
| SUS CO.,LTD. | Directeur/Bestuurslid | 01-12-2018 | - |
| Corporate Officer/Principal | 01-10-2018 | - | |
| Cross Reality Co., Ltd. | Directeur/Bestuurslid | 01-09-2019 | - |
Loopbaan van Tomosada Yoshikawa
Eerdere bekende functies van Tomosada Yoshikawa
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TELLA, INC. | Directeur/Bestuurslid | 01-03-2018 | 27-03-2019 |
| Independent Dir/Board Member | 01-03-2018 | 27-03-2019 | |
| TAIKO PHARMACEUTICAL CO.,LTD. | Hoofd Administratief Officier | 01-06-2009 | - |
| Directeur/Bestuurslid | 01-06-2007 | - | |
| Financieel Directeur/CFO | 04-01-2011 | 01-06-2013 | |
| Investor Relations Contact | 01-06-2009 | - |
Opleiding van Tomosada Yoshikawa
| Babson College | Masters Business Admin |
| Kwansei Gakuin University | Undergraduate Degree |
Statistieken
Internationaal
| Japan | 7 |
| Verenigde Staten | 2 |
Operationeel
| Director/Board Member | 5 |
| Independent Dir/Board Member | 2 |
| Chief Administrative Officer | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 3 |
| Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| KLAB INC. | Technology Services |
| SUS CO.,LTD. | Commercial Services |
| TAIKO PHARMACEUTICAL CO.,LTD. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Cross Reality Co., Ltd. | |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Beurs
- Insiders
- Tomosada Yoshikawa
- Ervaring
